Sullivan Lara → Pyxis Oncology, Inc. PYXS

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-07-15

DTC 3.11

3,253,653 shares short · +42.1% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $216K

Point72 Asset Mgmt

Other 13D/G Filings on Pyxis Oncology, Inc.

Filed	Form	Filer	Stake	Shares
2026-07-10	SCHEDULE 13G	BIOTECHNOLOGY VALUE FUND L P	—	—	view →
2026-07-02	SCHEDULE 13G/A	GordonMD Global Investments LP	—	—	view →
2025-04-02	SCHEDULE	Sullivan Lara	11.21%	7,543,007	view →

Other Filings by Sullivan Lara

Filed	Form	Issuer	Stake	Shares
2025-04-02	SCHEDULE	Pyxis Oncology, Inc. PYXS	11.21%	7,543,007	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →